Sign in Subscribe
United States. Securities and Exchange Commission

Vertex Pharmaceuticals Inc. Files SEC Form 4 with One Document

Strategic Insights

— 1 min read

Vertex Pharmaceuticals Inc. filed a U.S. Securities and Exchange Commission (SEC) form 4 on June 26, 2015, disclosing one document related to the company's financial activities. As a publicly-traded biotechnology company, Vertex Pharmaceuticals is subject to regular SEC filings, providing transparency into its financial dealings and corporate governance.

Key Takeaways:

  • The SEC filing was made on June 26, 2015, and is publicly available on the SEC website.
  • The filing was made by Vertex Pharmaceuticals Inc. under the SIC code 2834 for Pharmaceutical Preparations.
  • The contact information for the company is 50 Northern Avenue, Boston, MA 02210, with a phone number of 617-341-6393.
  • The SEC filing requires disclosure of ownership and changes in equity securities by directors, officers, and owners of more than 10% of registered equity securities.
  • The filing includes information on the reporting person's relationship to the company and purchases/sales of equity securities.
  • Form 4 is used for reporting changes in beneficial ownership of securities, while Form 3 is for the initial filing and Form 5 is for the annual statement of beneficial ownership.

Vertex Pharmaceuticals CEO Jacob van Naarden and SVP of Finance, Fran Hatzes, are not involved in this filing. The company's financial data is available on the SEC website, including the previously filed form, 10-Q, dated May 5, 2015.

Statistics:

  • June 26, 2015, is the date of the SEC filing.
  • 1 document was filed with Form 4.
  • The SEC file number is 0001209191-15-056756.
  • The company's SIC code is 2834, Pharmaceutical Preparations.
  • The contact information is 50 Northern Avenue, Boston, MA 02210, 617-341-6393.
  • The filing requires disclosure of ownership and changes in equity securities.

Sources:

  • U.S. Securities and Exchange Commission (SEC), Vertex Pharmaceuticals Inc. (Form 4) filing dated June 26, 2015.
  • NewsRx, "Vertex Pharmaceuticals Inc. Files SEC Form 4 with One Document" (July 13, 2015).
  • SEC, "EDGAR Database," [http://www.sec.gov/Archives/edgar/data/1197023/0001209191-15-056756-index.html].

Read more